Based on the TCGA database, the CGGA database, and clinical tissue samples, CXCL8 expression was significantly higher in glioma tissues than in non-tumor tissues, and its expression was significantly higher in high-grade glioma tissues than in low-grade glioma tissues. This evidence concerns the gene CXCL8 and central nervous system cancer.